Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q3 2023)

As of Sep 30, 2023, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Nov 14, 2023. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q3 2023, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q3 2023
64132K201
NeuBase Therapeutics
Sell - Position Exit
-12,601
Q3 2023
A
Agilent Technologies, Inc.
Sell
-97,700
Q3 2023
AA
Alcoa Corporation
Sell
-568,000
Q3 2023
AADI
Aadi Bioscience, Inc.
Buy
+41,800
Q3 2023
AAL
American Airlines Group, Inc.
Buy
+5,325,600
Q3 2023
AAME
Atlantic American Corporation
Buy
+1,400
Q3 2023
AAN
Buy
+30,900
Q3 2023
AAOI
Applied Optoelectronics, Inc.
Buy
+587,479
Q3 2023
AAON
AAON, Inc.
Sell
-255
Q3 2023
AAP
Advance Auto Parts Inc.
Sell
-88,431
Q3 2023
AAPL
Apple Inc.
Sell
-720,189
Q3 2023
AAT
American Assets Trust, Inc.
Buy - Position Entry
+49,901
Q3 2023
AAXJ
iShares MSCI All Country Asia e
Sell
-21,700
Q3 2023
ABBV
AbbVie Inc.
Buy
+70,991
Q3 2023
ABCB
Ameris Bancorp
Sell - Position Exit
-19,769
Q3 2023
ABCL
AbCellera Biologics Inc.
Sell
-844,550
Q3 2023
ABEO
Abeona Therapeutics Inc.
Sell
-2,700
Q3 2023
ABEV
Ambev S.A.
Sell
-1,095,996
Q3 2023
ABG
Asbury Automotive Group Inc
Buy - Position Entry
+21,400
Q3 2023
Buy
+6,300
Q3 2023
ABM
ABM Industries Incorporated
Sell - Position Exit
-56,500
Q3 2023
ABNB
Airbnb, Inc.
Sell
-791,271
Q3 2023
ABOS
Acumen Pharmaceuticals, Inc.
Buy
+42,600
Q3 2023
ABSI
Absci Corporation
Sell
-122,575
Q3 2023
ABT
Abbott Laboratories
Sell
-857,603
Q3 2023
ABUS
Arbutus Biopharma Corporation
Sell - Position Exit
-321,128
Q3 2023
AC
Associated Capital Group, Inc.
Buy
+3,000
Q3 2023
ACA
Arcosa, Inc.
Buy
+13,700
Q3 2023
ACAD
ACADIA Pharmaceuticals Inc.
Sell - Position Exit
-130,800
Q3 2023
ACCD
Accolade, Inc.
Sell
-89,600
Page 1 of 120